...
search icon
gmed-img

Globus Medical, Common Stock

GMED

NYQ

$72.32

-$0.3

(-0.41%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.54B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
96.8267
Volume info-icon
This is the total number of shares traded during the most recent trading day.
877.58K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.29
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$49.33 L
$94.93 H
$72.32

About Globus Medical, Common Stock

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameGMEDSectorS&P500
1-Week Return3.24%2.62%4.57%
1-Month Return-1.19%-5.07%-1.46%
3-Month Return-22.05%-4.85%-8.49%
6-Month Return-2.64%-6.6%-5.3%
1-Year Return42.92%-1.3%8.02%
3-Year Return9.23%6.38%33.73%
5-Year Return45.83%38.34%87.95%
10-Year Return193.55%90.57%162.37%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue789.04M958.10M1.02B1.57B2.52B[{"date":"2020-12-31","value":31.32,"profit":true},{"date":"2021-12-31","value":38.03,"profit":true},{"date":"2022-12-31","value":40.6,"profit":true},{"date":"2023-12-31","value":62.26,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue217.46M239.22M263.73M548.17M1.04B[{"date":"2020-12-31","value":21,"profit":true},{"date":"2021-12-31","value":23.1,"profit":true},{"date":"2022-12-31","value":25.47,"profit":true},{"date":"2023-12-31","value":52.94,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit571.58M718.88M759.12M1.02B1.48B[{"date":"2020-12-31","value":38.52,"profit":true},{"date":"2021-12-31","value":48.45,"profit":true},{"date":"2022-12-31","value":51.16,"profit":true},{"date":"2023-12-31","value":68.76,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin72.44%75.03%74.22%65.05%58.90%[{"date":"2020-12-31","value":96.55,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.91,"profit":true},{"date":"2023-12-31","value":86.7,"profit":true},{"date":"2024-12-31","value":78.5,"profit":true}]
Operating Expenses456.11M524.02M522.87M887.16M1.32B[{"date":"2020-12-31","value":34.61,"profit":true},{"date":"2021-12-31","value":39.76,"profit":true},{"date":"2022-12-31","value":39.67,"profit":true},{"date":"2023-12-31","value":67.32,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income111.43M171.95M227.95M133.14M165.99M[{"date":"2020-12-31","value":48.88,"profit":true},{"date":"2021-12-31","value":75.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":58.41,"profit":true},{"date":"2024-12-31","value":72.82,"profit":true}]
Total Non-Operating Income/Expense28.42M17.75M29.30M52.38M(49.46M)[{"date":"2020-12-31","value":54.25,"profit":true},{"date":"2021-12-31","value":33.89,"profit":true},{"date":"2022-12-31","value":55.94,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-94.42,"profit":false}]
Pre-Tax Income125.90M180.41M243.02M165.39M120.72M[{"date":"2020-12-31","value":51.81,"profit":true},{"date":"2021-12-31","value":74.24,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":68.06,"profit":true},{"date":"2024-12-31","value":49.68,"profit":true}]
Income Taxes23.61M31.22M52.85M42.52M17.74M[{"date":"2020-12-31","value":44.68,"profit":true},{"date":"2021-12-31","value":59.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.45,"profit":true},{"date":"2024-12-31","value":33.56,"profit":true}]
Income After Taxes102.28M149.19M190.17M122.87M102.98M[{"date":"2020-12-31","value":53.79,"profit":true},{"date":"2021-12-31","value":78.45,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.61,"profit":true},{"date":"2024-12-31","value":54.15,"profit":true}]
Income From Continuous Operations102.28M149.19M190.17M122.87M102.98M[{"date":"2020-12-31","value":53.79,"profit":true},{"date":"2021-12-31","value":78.45,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.61,"profit":true},{"date":"2024-12-31","value":54.15,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income102.28M149.19M190.17M122.87M102.98M[{"date":"2020-12-31","value":53.79,"profit":true},{"date":"2021-12-31","value":78.45,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.61,"profit":true},{"date":"2024-12-31","value":54.15,"profit":true}]
EPS (Diluted)1.432.042.072.333.14[{"date":"2020-12-31","value":45.54,"profit":true},{"date":"2021-12-31","value":64.97,"profit":true},{"date":"2022-12-31","value":65.92,"profit":true},{"date":"2023-12-31","value":74.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

GMED
Cash Ratio 1.04
Current Ratio 2.54
Quick Ratio 1.77

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GMED
ROA (LTM) 5.33%
ROE (LTM) 2.52%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GMED
Debt Ratio Lower is generally better. Negative is bad. 0.20
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.80

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GMED
Trailing PE 96.83
Forward PE 21.14
P/S (TTM) 3.98
P/B 2.40
Price/FCF 52
EV/R 3.83
EV/Ebitda 20.39
PEG 1.92

FAQs

What is Globus Medical share price today?

Globus Medical (GMED) share price today is $72.32

Can Indians buy Globus Medical shares?

Yes, Indians can buy shares of Globus Medical (GMED) on Vested. To buy Globus Medical from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GMED stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Globus Medical be purchased?

Yes, you can purchase fractional shares of Globus Medical (GMED) via the Vested app. You can start investing in Globus Medical (GMED) with a minimum investment of $1.

How to invest in Globus Medical shares from India?

You can invest in shares of Globus Medical (GMED) via Vested in three simple steps:

  • Click on Sign Up or Invest in GMED stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Globus Medical shares
What is Globus Medical 52-week high and low stock price?

The 52-week high price of Globus Medical (GMED) is $94.93. The 52-week low price of Globus Medical (GMED) is $49.33.

What is Globus Medical price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Globus Medical (GMED) is 96.8267

What is Globus Medical price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Globus Medical (GMED) is 2.40

What is the Market Cap of Globus Medical?

The market capitalization of Globus Medical (GMED) is $9.54B

What is Globus Medical’s stock symbol?

The stock symbol (or ticker) of Globus Medical is GMED

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top